MedPath
HSA Approval

BETAMOX GRANULES 125 mg/5 ml

SIN04143P

BETAMOX GRANULES 125 mg/5 ml

BETAMOX GRANULES 125 mg/5 ml

April 20, 1990

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

GRANULE, FOR SUSPENSION

ORAL

Medical Information

J01CA04

amoxicillin

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

125 mg/5 ml

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BETAMOX GRANULES 125 mg/5 ml - HSA Approval | MedPath